Navigation Links
Can cancer be turned against itself?
Date:2/4/2013

Though a small group of proteins, the family called Ras controls a large number of cellular functions, including cell growth, differentiation, and survival. And because the protein has a hand in cellular division, mutated Ras, which can be detected in one-third of all tumors, contributes to many human cancers by allowing for the rapid growth of diseased cells.

Now Prof. Yoel Kloog of Tel Aviv University's Department of Neurobiology, along with Dr. Itamar Goldstein of TAU's Sackler Faculty of Medicine and the Sheba Medical Center and their students Helly Vernitsky and Dr. Oded Rechavi, has found that oncogenic Ras, which promotes cancer development, can also alert the immune system to the presence of cancer cells.

For the first time, the researchers have shown the transfer of oncogenic Ras in human cells from melanoma cells to T cells, which belong to a group of white blood cells that are part of the immune system. This transfer allows the immune cells to gather crucial intelligence on what they are fighting and develop the necessary cytokines, or signalling molecules, to kill the melanoma cells.

Prof. Kloog suggests that a drug that enhances the transfer of the oncogene from the tumor to the immune cells is a potential therapy to augment the anti-cancer immune response. This research has been published in the Journal of Immunology.

Finding the tipping point

Although they found that immune cells often exchange proteins among themselves, the discovery that melanoma cells transfer mutated Ras is an intriguing first. And it's this initial transfer that begins what the researchers call a positive feedback loop.

In the lab, researchers incubated T-cells from patients with human melanoma cells that had originated from tumors to track the process of handing-off various proteins. They uncovered a circuit that runs between the cancer and immune cells. Once the melanoma cells pass oncogenic Ras to the T-c
'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Page: 1 2

Related biology news :

1. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
2. Pitt researchers reveal mechanism to halt cancer cell growth, discover potential therapy
3. Quantum dots deliver Vitamin D to tumors for possible inflammatory breast cancer treatment
4. How the tilt of a cell-surface receptor prevents cancer
5. The potential of psilocybin to alleviate psychological distress in cancer patients is revealed
6. Brupbacher Prize goes to cancer researcher Michael Karin
7. Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists
8. In breast cancer metastasis, researchers identify possible drug target
9. Planning for bacteria in cancer patients may help hospitals fight infections
10. TGen, Scottsdale Healthcare study shows drug combination extends pancreatic cancer patient survival
11. Vitamin D holds promise in battling a deadly breast cancer, Saint Louis University researchers say
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/12/2015)... 2015  Securus Technologies, a leading provider of ... safety, investigation, corrections and monitoring, announced the United ... capture, analyze and identify participants of a video ... This system can: , Identify ... subsequent sign-on process is actually the person participating ...
(Date:6/9/2015)... Minn. , June 9, 2015   MedNet ... supports the entire spectrum of clinical research, will be ... eClinical technology platform at the 2015 Drug Information Association ... on June 15-17.  These presentations will include previews ... rolled out in the upcoming iMedNet 2015 ...
(Date:6/8/2015)... June 8, 2015  The Secure Identity ... selection of Troy Potter of L-3 ... SIBA is a non-profit association that was established ... education and implementation of solutions that protect and ... ...
Breaking Biology News(10 mins):Securus Announces Patent Issued for Authorized Presence Verification During Video Visitation 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... VANCOUVER, BRITISH COLUMBIA Parents of children with chronic ... to a study being presented Monday, May 3 at ... British Columbia, Canada. Medication use in children with ... been done on mistakes made by parents giving these ...
... in complex networks that govern cellular processes, much like people ... discovering how biological networks change and are rewired in cancer. ... ( www.genome.org ), scientists have analyzed the genetic networks ... awry in disease. MicroRNAs (miRNAs) are short RNA molecules ...
... , STANFORD, Calif. - Life is almost unbearably complex. ... and off in dizzying combinations and sequences during their ... to understand the machinations of the proteins behind the ... their disposal, courtesy of researchers at the Stanford University ...
Cached Biology News:Home medication errors common among children with chronic conditions 2MicroRNA network study implicates rewired interactions in cancer 2New Stanford tool enables wider analyses of genome 'deep sequencing' 2New Stanford tool enables wider analyses of genome 'deep sequencing' 3
(Date:6/26/2015)... ... June 26, 2015 , ... DNA Genotek, a leading provider ... Inc. (Nasdaq: OSUR) today announced that it has awarded grants to three organizations ... Program. The company has awarded its OMNIgene®â€¢GUT fecal/stool collection kits and ...
(Date:6/25/2015)... 25, 2015 ... announced the addition of the  "2015 ... Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... Commercial Labs, POC Locations"  report ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , A ...
(Date:6/25/2015)... , June 25, 2015  BioMed Realty Trust, ... Inc. (NASDAQ: ILMN ), a world leader in ... power of the genome, has signed a 20-year lease ... research building in Cambridge, England . ... access to the highly skilled workforce in the dynamic ...
(Date:6/25/2015)... TORONTO , June 25, 2015 /PRNewswire/ - Portage ... PBT.U , OTC Markets : PTGEF,), is pleased to ... raising US$5,155,080 through issuance of approximately 36.8 million common ... in two tranches, first tranche closed on June 15, ... 2015 and second and final tranche closed on June ...
Breaking Biology Technology:DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 3Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 2Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 3BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 2BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 3Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 2Portage Completes Non-brokered Private Placement in Two Tranches for a Total Proceeds of US$ 5,155,080 3
... 6 /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin ... leading manufacturer and distributor,of high-quality, pharmaceutical grade ... products that serve as raw materials for ... it will conduct a conference,call at 9:00 ...
... Expands the Company,s Clinical Stage Product Portfolio ... Meditrina Pharmaceuticals,Inc. today announced that it ... make, develop and commercialize products under AstraZeneca,s ... inhibitors (AI) in combination with,estrogen and progestin ...
... Inc. ("Senesco" or the "Company") (Amex: SNT ... focused on multiple myeloma that,were conducted concurrently at ... of these studies, which utilized two different dosing ... Factor 5A technology to induce,apoptosis in tumors. Additionally, ...
Cached Biology Technology:Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 2Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008 3Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 2Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca 3Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies 2Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies 3
BD Falcon insert HTS 96 well, square A-bottom with lid. PET membrane, sterile. (5/ca) Packaging: 5 / pack, 5 / case ...
... NIS-Elements revolutionizes imaging software for the ... to microscopes, cameras, components and peripherals ... achiving tools. Its intuitive interface simplifies ... times while providing powerful features such ...
...
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine....
Biology Products: